Skip to main content
. 2011 Nov 9;1:146. doi: 10.1038/srep00146

Figure 5. Plasma membrane expression of WT TRPM6 and the putative PIP2 binding-site mutants.

Figure 5

(A) Western-blot (with GFP antibody) detection of proteins of the WT and mutants in the plasma membrane portion and in total lysate. GADPH was used as a negative control for the plasma membrane protein. (B) Mean relative expression level of WT TRPM6 and the mutants in the plasma membrane versus total protein. No statistically significant difference was observed (n = 3).